COH:ASX
Cochlear Ltd
A$151.37
arrow_downward
-1.05%(-1.61) 1D
Nov 13, 4:10:12 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COH...
Open
A$151.50
High
A$152.79
Low
A$150.48
Mkt. cap
9.90B
Avg. vol.
447.88K
Volume
172.60K
Dividend
2.28%
Quarterly dividend
A$0.86
Ex-dividend date
Sep 21, 2026
P/E ratio
67.35
52-wk high
A$287.00
52-wk low
A$88.74
EPS
A$2.25
Shares outstanding
65.40M
No. of employees
5K
Open
A$151.50
High
A$152.79
Low
A$150.48
Mkt. cap
9.90B
Avg. vol.
447.88K
Volume
172.60K
Dividend
2.28%
Quarterly dividend
A$0.86
Ex-dividend date
Sep 21, 2026
P/E ratio
67.35
52-wk high
A$287.00
52-wk low
A$88.74
EPS
A$2.25
Shares outstanding
65.40M
No. of employees
5K
News stories
From web sources and news partners
Stocks Down Under
·
1 day ago
Cochlear (ASX:COH) reaffirms A$330-350m FY27 profit
www.marketscreener.com
·
1 day ago
Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2027
Profile
Cochlear Limited is a medical device company that designs, manufactures, and supplies implantable hearing systems. Its principal products include the Nucleus range of cochlear implants and the Baha and Osia bone conduction hearing systems.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate.
As of 2026, the company holds 60% of the cochlear implant market, with more than 800,000 people receiving one of Cochlear's implants. Wikipedia
About Cochlear Ltd
CEODig Howitt
Employees5.4K
Founded1981
HeadquartersSydney, New South Wales, Australia
SectorHealth Care
IndustryMedical device
Websitecochlear.com